Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
Canada: PrEP use now could save considerable sums in the future

A Canadian paper that weighs the cost of using pre-exposure prophylaxis (PrEP) to prevent HIV infections against the lifetime total cost of one HIV infection finds that,

Published
20 March 2015
By
Gus Cairns
England government unveils £650k in new HIV spending

The English Government has revealed that £800,000 of new money will be spent on HIV prevention, and to reduce the numbers of late diagnoses. A new £500,000 innovation fund was unveiled, which has been administered by Public Health England (PHE), and will allow small organisations to bid for funding of up to £50,000.

Published
13 March 2015
From
Pink News
From the Gates Foundation, Direct Investment, Not Just Grants

The Bill & Melinda Gates Foundation, which has distributed billions of dollars in grants to improve health and living conditions in developing countries, is increasingly expanding its tool kit, using some of its capital to invest directly in companies that could help advance its goals.

Published
13 March 2015
From
New York Times
Hepatitis C pills drive surge in U.S. drug costs: report

Highly effective but expensive new pills to treat hepatitis C drove a 13.1 percent increase U.S. prescription drug spending in 2014, the fastest rate of increase in more than a decade, according to Express Scripts.

Published
12 March 2015
From
Reuters
Alternative way to pay for expensive drugs may be needed, analysis says

A major challenge facing the world's health care systems is paying for a new breed of expensive breakthrough drugs. One way to address the issue is to approach it the same way as other industries where suppliers encourage investment through approaches such as equipment leases or supplier-financed credit.

Published
11 March 2015
From
Eurekalert Medicine & Health
HCV Drugs Costly but Cure Might Not Be

Despite controversy over the cost of new hepatitis C (HCV) medications, they appear to be cheaper on a per-cure basis than earlier drugs, a researcher said here.

Published
04 March 2015
From
MedPage Today
Payment delays dent India's flagship health, AIDS programs

India's main public health programs, aimed at millions of rural poor, have been in disarray for months because the government changed the way that over $1.3 billion in federal funds were distributed, according to data and letters seen by Reuters.

Published
03 March 2015
From
Reuters
London HIV Prevention Contract awarded to GMI Partnership & NHS Freedoms Shop

The leading London HIV Prevention provider GMI Partnership led by METRO Charity with Positive East and West London Gay Men's Project and working with NHS Freedoms Shop has been awarded just under £1 million over two years to continue to provide outreach and condom distribution across London to gay and bisexual men and other men who have sex with men (MSM).

Published
03 March 2015
From
Metro Centre press release
Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world's most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits overseas.

Published
27 February 2015
From
Chicago Tribune
HIV Prevention Cuts Medical Costs

Averting a single infection could save up to $338,000 over a lifetime.

Published
27 February 2015
From
MedPage Today HIV/AIDS
← First12345...74Next →

Filter by country